$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
Quick summary
arXiv:2601.06300v2 Announce Type: replace-cross Abstract: Clinical trial amendments frequently introduce delays, increased costs, and administrative burden, with eligibility criteria being the most commonly amended component. We introduce \textit{eligibility criteria amendment prediction}, a novel NLP task that aims to forecast whether the eligibility criteria of an initial trial protocol will undergo future amendments. To support this task, we release $\texttt{AMEND++}$, a benchmark suite comprising two datasets: $\texttt{AMEND}$, which captures eligibility-criteria version histories and amen
Key takeaways
- arXiv:2601.06300v2 Announce Type: replace-cross Abstract: Clinical trial amendments frequently introduce delays, increased costs, and administrative burden, with eligibility criteria being the most commonly amended component.
- We introduce \textit{eligibility criteria amendment prediction}, a novel NLP task that aims to forecast whether the eligibility criteria of an initial trial protocol will undergo future amendments.
- To support this task, we release $\texttt{AMEND++}$, a benchmark suite comprising two datasets: $\texttt{AMEND}$, which captures eligibility-criteria version histories and amen
Why it matters
“$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials” highlights the need for repeatable measurement rather than a single impressive demonstration. Independent validation across datasets and clearly stated limitations determine whether a result can guide product decisions.